You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Devices & Consumables

Global Commercial Aquaculture Vaccines Market Research Report 2021, Competitive Analysis, Industry Growth Trends And Forecast 2027

Commercial Aquaculture Vaccines Are Approved Vaccines That Can Induce Protective Immune Responses In Aquatic Animals. The Mass Production Of Aquatic Species Leads To Changes In Optimal Breeding Conditions, Which Indicates Increased Sensitivity To Infectious/Viral Diseases, Thereby Increasing Increased Demand For Commercial Aquaculture Vaccines, Bacterial Diseases And Zoonotic Infections, Are Major Obstacles To Successful Aquaculture. Facts Have Proved That Commercial Aquaculture Vaccines Are A Better Alternative To Antibiotics Used In Fish Aquaculture, Because Antibiotic Treatment Has Attracted A Lot Of Attention Due To Adverse Effects Such As Bacterial Resistance, Toxicity, And Residual Antibiotics In Aquaculture Food. In Addition, The Increase In Global Fish Consumption And The Prevalence Of Bacterial Infections Between Aquatic Species Are Also Increasing The Use Of Commercial Fish Aquaculture Vaccines.
The global Commercial Aquaculture Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
In terms of production side, this report researches the Commercial Aquaculture Vaccines production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Commercial Aquaculture Vaccines by regions (countries) and by Application.
The global Commercial Aquaculture Vaccines market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Commercial Aquaculture Vaccines market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Commercial Aquaculture Vaccines markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are United States, Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Commercial Aquaculture Vaccines market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
The report includes comprehensive company profiling of leading and emerging companies competing in the global Commercial Aquaculture Vaccines market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Commercial Aquaculture Vaccines market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Commercial Aquaculture Vaccines market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Commercial Aquaculture Vaccines market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Commercial Aquaculture Vaccines market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Commercial Aquaculture Vaccines market by each application segment for the same period.
This report includes the following manufacturers:
Zoetis LLC
Merck & Co. Inc. (MSD Animal Health)
Laboratorios Hipra S. A.
Elanco Animal Health Inc
Veterquimica S. A.
Nisseiken Co Ltd
Market Segment by Type
Nucleic Acid Vaccine
Subunit Vaccine
Live Attenuated Vaccine
Inactivated Vaccine
Market Segment by Application
Breeding Clinic
Fisheries Research Institute
Research Methodology
To compile the detailed study of the global Commercial Aquaculture Vaccines market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Commercial Aquaculture Vaccines market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Commercial Aquaculture Vaccines market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.

1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Commercial Aquaculture Vaccines Market Size Growth Rate by Type
1.2.2 Nucleic Acid Vaccine
1.2.3 Subunit Vaccine
1.2.4 Live Attenuated Vaccine
1.2.5 Inactivated Vaccine
1.3 Market Segment by Application
1.3.1 Global Commercial Aquaculture Vaccines Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Fisheries
1.3.3 Breeding Clinic
1.3.4 Fisheries Research Institute
1.4 Study Objectives
1.5 Years Considered

2 Market Perspective
2.1 Global Commercial Aquaculture Vaccines Market Size (2016-2027)
2.1.1 Global Commercial Aquaculture Vaccines Revenue (2016-2027)
2.1.2 Global Commercial Aquaculture Vaccines Sales (2016-2027)
2.2 Global Commercial Aquaculture Vaccines Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Commercial Aquaculture Vaccines Sales by Regions (2016-2021)
2.2.2 Global Commercial Aquaculture Vaccines Revenue by Regions (2016-2021)
2.3 Global Commercial Aquaculture Vaccines Market Size Forecast by Region
2.3.1 Global Commercial Aquaculture Vaccines Sales Forecast by Region (2022-2027)
2.3.2 Global Commercial Aquaculture Vaccines Revenue Forecast by Region (2022-2027)
2.4 Global Top Commercial Aquaculture Vaccines Regions (Countries) Ranking by Market Size
2.5 Commercial Aquaculture Vaccines Industry Trends
2.5.1 Commercial Aquaculture Vaccines Market Trends
2.5.2 Commercial Aquaculture Vaccines Market Drivers
2.5.3 Commercial Aquaculture Vaccines Market Challenges
2.5.4 Commercial Aquaculture Vaccines Market Restraints

3 Competitive Landscape by Manufacturers
3.1 Global Top Commercial Aquaculture Vaccines Manufacturers by Sales (2016-2021)
3.1.1 Global Commercial Aquaculture Vaccines Sales by Manufacturers (2016-2021)
3.1.2 Global Commercial Aquaculture Vaccines Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Commercial Aquaculture Vaccines Sales in 2020
3.2 Global Top Manufacturers Commercial Aquaculture Vaccines by Revenue
3.2.1 Global Commercial Aquaculture Vaccines Revenue by Manufacturers (2016-2021)
3.2.2 Top Commercial Aquaculture Vaccines Manufacturers Covered: Ranking by Revenue
3.2.3 Global Commercial Aquaculture Vaccines Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Commercial Aquaculture Vaccines Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Commercial Aquaculture Vaccines as of 2020)
3.4 Global Commercial Aquaculture Vaccines Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Commercial Aquaculture Vaccines Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Commercial Aquaculture Vaccines Market
3.7 Key Manufacturers Commercial Aquaculture Vaccines Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Global Commercial Aquaculture Vaccines Market Size by Type
4.1 Global Commercial Aquaculture Vaccines Historic Market Review by Type (2016-2021)
4.1.1 Global Commercial Aquaculture Vaccines Sales Market Share by Type (2016-2021)
4.1.2 Global Commercial Aquaculture Vaccines Revenue Market Share by Type (2016-2021)
4.1.3 Commercial Aquaculture Vaccines Price by Type (2016-2021)
4.2 Global Commercial Aquaculture Vaccines Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Commercial Aquaculture Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Commercial Aquaculture Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Commercial Aquaculture Vaccines Price Forecast by Type (2022-2027)

5 Global Commercial Aquaculture Vaccines Market Size by Application
5.1 Global Commercial Aquaculture Vaccines Historic Market Review by Application (2016-2021)
5.1.1 Global Commercial Aquaculture Vaccines Sales Market Share by Application (2016-2021)
5.1.2 Global Commercial Aquaculture Vaccines Revenue Market Share by Application (2016-2021)
5.1.3 Commercial Aquaculture Vaccines Price by Application (2016-2021)
5.2 Global Commercial Aquaculture Vaccines Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Commercial Aquaculture Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Commercial Aquaculture Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Commercial Aquaculture Vaccines Price Forecast by Application (2022-2027)

6 North America
6.1 North America Commercial Aquaculture Vaccines Sales Breakdown by Company
6.1.1 North America Commercial Aquaculture Vaccines Sales by Company (2016-2027)
6.1.2 North America Commercial Aquaculture Vaccines Revenue by Company (2016-2027)
6.2 North America Commercial Aquaculture Vaccines Market Size by Type (2016-2027)
6.2.1 North America Commercial Aquaculture Vaccines Sales by Type (2016-2027)
6.2.2 North America Commercial Aquaculture Vaccines Revenue by Type (2016-2027)
6.3 North America Commercial Aquaculture Vaccines Market Size by Application (2016-2027)
6.3.1 North America Commercial Aquaculture Vaccines Sales by Application (2016-2027)
6.3.2 North America Commercial Aquaculture Vaccines Revenue by Application (2016-2027)
6.4 North America Commercial Aquaculture Vaccines Market Size by Country
6.4.1 North America Commercial Aquaculture Vaccines Sales by Country (2016-2027)
6.4.2 North America Commercial Aquaculture Vaccines Revenue by Country (2016-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Commercial Aquaculture Vaccines Sales Breakdown by Company
7.1.1 Europe Commercial Aquaculture Vaccines Sales by Company (2016-2027)
7.1.2 Europe Commercial Aquaculture Vaccines Revenue by Company (2016-2027)
7.2 Europe Commercial Aquaculture Vaccines Market Size by Type (2016-2027)
7.2.1 Europe Commercial Aquaculture Vaccines Sales by Type (2016-2027)
7.2.2 Europe Commercial Aquaculture Vaccines Revenue by Type (2016-2027)
7.3 Europe Commercial Aquaculture Vaccines Market Size by Application (2016-2027)
7.3.1 Europe Commercial Aquaculture Vaccines Sales by Application (2016-2027)
7.3.2 Europe Commercial Aquaculture Vaccines Revenue by Application (2016-2027)
7.4 Europe Commercial Aquaculture Vaccines Market Size by Country
7.4.1 Europe Commercial Aquaculture Vaccines Sales by Country (2016-2027)
7.4.2 Europe Commercial Aquaculture Vaccines Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Commercial Aquaculture Vaccines Sales Breakdown by Company
8.1.1 Asia Pacific Commercial Aquaculture Vaccines Sales by Company (2016-2027)
8.1.2 Asia Pacific Commercial Aquaculture Vaccines Revenue by Company (2016-2027)
8.2 Asia Pacific Commercial Aquaculture Vaccines Market Size by Type (2016-2027)
8.2.1 Asia Pacific Commercial Aquaculture Vaccines Sales by Type (2016-2027)
8.2.2 Asia Pacific Commercial Aquaculture Vaccines Revenue by Type (2016-2027)
8.3 Asia Pacific Commercial Aquaculture Vaccines Market Size by Application (2016-2027)
8.3.1 Asia Pacific Commercial Aquaculture Vaccines Sales by Application (2016-2027)
8.3.2 Asia Pacific Commercial Aquaculture Vaccines Revenue by Application (2016-2027)
8.4 Asia Pacific Commercial Aquaculture Vaccines Market Size by Regions
8.4.1 Asia Pacific Commercial Aquaculture Vaccines Sales by Regions
8.4.2 Asia Pacific Commercial Aquaculture Vaccines Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia

9 Latin America
9.1 Latin America Commercial Aquaculture Vaccines Sales Breakdown by Company
9.1.1 Latin America Commercial Aquaculture Vaccines Sales by Company (2016-2027)
9.1.2 Latin America Commercial Aquaculture Vaccines Revenue by Company (2016-2027)
9.2 Latin America Commercial Aquaculture Vaccines Market Size by Type (2016-2027)
9.2.1 Latin America Commercial Aquaculture Vaccines Sales by Type (2016-2027)
9.2.2 Latin America Commercial Aquaculture Vaccines Revenue by Type (2016-2027)
9.3 Latin America Commercial Aquaculture Vaccines Market Size by Application (2016-2027)
9.3.1 Latin America Commercial Aquaculture Vaccines Sales by Application (2016-2027)
9.3.2 Latin America Commercial Aquaculture Vaccines Revenue by Application (2016-2027)
9.4 Latin America Commercial Aquaculture Vaccines Market Size by Country
9.4.1 Latin America Commercial Aquaculture Vaccines Sales by Country (2016-2027)
9.4.2 Latin America Commercial Aquaculture Vaccines Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Commercial Aquaculture Vaccines Sales Breakdown by Company
10.1.1 Middle East and Africa Commercial Aquaculture Vaccines Sales by Company (2016-2027)
10.1.2 Middle East and Africa Commercial Aquaculture Vaccines Revenue by Company (2016-2027)
10.2 Middle East and Africa Commercial Aquaculture Vaccines Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Commercial Aquaculture Vaccines Sales by Type (2016-2027)
10.2.2 Middle East and Africa Commercial Aquaculture Vaccines Revenue by Type (2016-2027)
10.3 Middle East and Africa Commercial Aquaculture Vaccines Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Commercial Aquaculture Vaccines Sales by Application (2016-2027)
10.3.2 Middle East and Africa Commercial Aquaculture Vaccines Revenue by Application (2016-2027)
10.4 Middle East and Africa Commercial Aquaculture Vaccines Market Size by Country
10.4.1 Middle East and Africa Commercial Aquaculture Vaccines Sales by Country (2016-2027)
10.4.2 Middle East and Africa Commercial Aquaculture Vaccines Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Company Profiles
11.1 Zoetis LLC
11.1.1 Zoetis LLC Corporation Information
11.1.2 Zoetis LLC Overview
11.1.3 Zoetis LLC Commercial Aquaculture Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Zoetis LLC Commercial Aquaculture Vaccines Products and Services
11.1.5 Zoetis LLC Commercial Aquaculture Vaccines SWOT Analysis
11.1.6 Zoetis LLC Recent Developments
11.2 Merck & Co. Inc. (MSD Animal Health)
11.2.1 Merck & Co. Inc. (MSD Animal Health) Corporation Information
11.2.2 Merck & Co. Inc. (MSD Animal Health) Overview
11.2.3 Merck & Co. Inc. (MSD Animal Health) Commercial Aquaculture Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Merck & Co. Inc. (MSD Animal Health) Commercial Aquaculture Vaccines Products and Services
11.2.5 Merck & Co. Inc. (MSD Animal Health) Commercial Aquaculture Vaccines SWOT Analysis
11.2.6 Merck & Co. Inc. (MSD Animal Health) Recent Developments
11.3 Laboratorios Hipra S. A.
11.3.1 Laboratorios Hipra S. A. Corporation Information
11.3.2 Laboratorios Hipra S. A. Overview
11.3.3 Laboratorios Hipra S. A. Commercial Aquaculture Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Laboratorios Hipra S. A. Commercial Aquaculture Vaccines Products and Services
11.3.5 Laboratorios Hipra S. A. Commercial Aquaculture Vaccines SWOT Analysis
11.3.6 Laboratorios Hipra S. A. Recent Developments
11.4 Elanco Animal Health Inc
11.4.1 Elanco Animal Health Inc Corporation Information
11.4.2 Elanco Animal Health Inc Overview
11.4.3 Elanco Animal Health Inc Commercial Aquaculture Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Elanco Animal Health Inc Commercial Aquaculture Vaccines Products and Services
11.4.5 Elanco Animal Health Inc Commercial Aquaculture Vaccines SWOT Analysis
11.4.6 Elanco Animal Health Inc Recent Developments
11.5 Veterquimica S. A.
11.5.1 Veterquimica S. A. Corporation Information
11.5.2 Veterquimica S. A. Overview
11.5.3 Veterquimica S. A. Commercial Aquaculture Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 Veterquimica S. A. Commercial Aquaculture Vaccines Products and Services
11.5.5 Veterquimica S. A. Commercial Aquaculture Vaccines SWOT Analysis
11.5.6 Veterquimica S. A. Recent Developments
11.6 Ictyogroup
11.6.1 Ictyogroup Corporation Information
11.6.2 Ictyogroup Overview
11.6.3 Ictyogroup Commercial Aquaculture Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Ictyogroup Commercial Aquaculture Vaccines Products and Services
11.6.5 Ictyogroup Commercial Aquaculture Vaccines SWOT Analysis
11.6.6 Ictyogroup Recent Developments
11.7 Tecnovax
11.7.1 Tecnovax Corporation Information
11.7.2 Tecnovax Overview
11.7.3 Tecnovax Commercial Aquaculture Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 Tecnovax Commercial Aquaculture Vaccines Products and Services
11.7.5 Tecnovax Commercial Aquaculture Vaccines SWOT Analysis
11.7.6 Tecnovax Recent Developments
11.8 Nisseiken Co Ltd
11.8.1 Nisseiken Co Ltd Corporation Information
11.8.2 Nisseiken Co Ltd Overview
11.8.3 Nisseiken Co Ltd Commercial Aquaculture Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Nisseiken Co Ltd Commercial Aquaculture Vaccines Products and Services
11.8.5 Nisseiken Co Ltd Commercial Aquaculture Vaccines SWOT Analysis
11.8.6 Nisseiken Co Ltd Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Commercial Aquaculture Vaccines Value Chain Analysis
12.2 Commercial Aquaculture Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Commercial Aquaculture Vaccines Production Mode & Process
12.4 Commercial Aquaculture Vaccines Sales and Marketing
12.4.1 Commercial Aquaculture Vaccines Sales Channels
12.4.2 Commercial Aquaculture Vaccines Distributors
12.5 Commercial Aquaculture Vaccines Customers
13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 130